Vision Drugs Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 20-12-2024
- Paid Up Capital ₹ 6.89 Cr
as on 20-12-2024
- Company Age 19 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 107.94 Cr
as on 20-12-2024
- Satisfied Charges ₹ 9.14 Cr
as on 20-12-2024
- Revenue 15.24%
(FY 2022)
- Profit -70.45%
(FY 2022)
- Ebitda -32.67%
(FY 2022)
- Net Worth 10.52%
(FY 2022)
- Total Assets 52.38%
(FY 2022)
About Vision Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.89 Cr.
The company currently has active open charges totaling ₹107.94 Cr. The company has closed loans amounting to ₹9.14 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ram Rao, Haritha Polsani, and Battula Sheshu serve as directors at the Company.
- CIN/LLPIN
U99999TG2005PTC048204
- Company No.
048204
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vision Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Rao  | Managing Director | 13-Aug-2009 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Haritha Polsani | Director | 28-Aug-2012 | Current |
| Battula Sheshu | Director | 02-Feb-2022 | Current |
Financial Performance of Vision Drugs.
Vision Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.24% increase. The company also saw a substantial fall in profitability, with a 70.45% decrease in profit. The company's net worth Soared by an impressive increase of 10.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vision Drugs?
In 2022, Vision Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Phrm Chemicals Private LimitedActive 18 years 5 monthsRam Rao and Haritha Polsani are mutual person
- Sri Venkata Sai Minerals Private LimitedActive 28 years 6 months
Ram Rao and Haritha Polsani are mutual person
- Dr. Battula's Life Sciences Private LimitedActive 4 years 10 months
Battula Sheshu is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Oct 2024 | ₹2.00 Cr | Open |
Others Creation Date: 20 Aug 2024 | ₹2.25 Cr | Open |
Hdfc Bank Limited Creation Date: 04 Jun 2024 | ₹7.60 M | Open |
How Many Employees Work at Vision Drugs?
Vision Drugs has a workforce of 325 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vision Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vision Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
